Comparative clinical and airway inflammatory features of asthma with or without nasal polyposis

Rhinology

Volumn 48, Issue 4, 2010, Pages 420-425

  Bilodeau, Lara ^a   Boulay, Marie Ève ^a   Prince, Philippe ^a   Boisvert, Pierre ^b   Boulet, Louis Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Asthma; Asthma control; Eosinophil; Induced sputum; Nasal polyposis

Indexed keywords

ANTIASTHMATIC AGENT; EOSINOPHIL CATIONIC PROTEIN; FIBRONECTIN;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFECT; DRUG RESISTANCE; EOSINOPHIL; FEMALE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; NOSE POLYP; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SECRETION; SKIN TEST; SPIROMETRY; SPUTUM;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ANTI-ASTHMATIC AGENTS; ASTHMA; DISEASE PROGRESSION; DRUG RESISTANCE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX; SKIN TESTS; SPIROMETRY; SPUTUM;

EID: 79551587535     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhino09.095     Document Type: Article

References (33)

1. Grigoreas C, Vourdas D, Petalas K, et al. Nasal polyps in patients with rhinitis and asthma. Allergy Asthma Proc 2002; 23: 169-174.
2. Ceylan E, Gencer M, San I. Nasal polyps and the severity of asthma. Respirology 2007; 12: 272-276.
3. Van der Baan B. Epidemiology and natural history. In: Mygind N and Lildholdt T, eds. Nasal polyposis: an inflammatory disease and its treatment. Cpenhagen: Munksgaard, 1997; 13-16.
4. Jeffery PK, and Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 2006; 6 Suppl 1:S5.
5. ten Brinke A, Sterk PJ, Masclee AA et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005; 26: 812-818.
6. Dunlop G, Scadding GK, Lund VJ. The effect of endoscopic sinus surgery on asthma: management of patients with chronic rhinosinusitis, nasal polyposis, and asthma. Am J Rhinol 1999; 13: 261-265.
7. Ragab SM, Lund VJ, Saleh HA, et al. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. 2006; 61: 717-724.
8. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003; 3:1-6.
9. Lamblin C, Gosset P, Salez F et al. Eosinophilic airway inflammation in nasal polyposis. J Allergy Clin Immunol 1999; 104: 85-92.
10. Lamblin C, Bolard F, Gosset P et al. Bronchial interleukin-5 and eotaxin expression in nasal polyposis. Relationship with (asymptomatic bronchial hyperresponsiveness. Am J Respir Crit Care Med 2001; 163: 1226-1232.
11. Ediger D, Sin BA, Heper A, et al. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma. Clin Exp Allergy 2005; 35: 319-326.
12. ten Brinke A, Grootendorst DC, Schmidt JT et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002; 109: 621-626.
13. Bachert C, Gevaert P, Holtappels G, et al. Mediators in nasal polyposis. Curr Allergy Asthma Rep 2002; 2: 481-487.
14. Bachert C, Gevaert P, Holtappels G, et al. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000; 14: 279-290.
15. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep 2005; 5: 463-471.
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
17. Boulet LP, Becker AB, Bérubé D, et al. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 1999; 161: S1-S62.
18. Boulet LP, Boulet V, Milot J. How should we quantify asthma control? Chest 2002; 122: 2217-2223.
19. LeBlanc A, Robichaud P, Lacasse Y, et al. Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy 2007; 62: 120-125.
20. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
21. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734.
22. Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145: 1265-1269.
23. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
24. Radenne F, Lamblin C, Vandezande LM, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999; 104: 79-84.
25. Alobid I, Benitez P, Bernal-Sprekelsen M, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 2005; 60: 452-458.
26. Alobid I, Benitez P, Bernal-Sprekelsen M, et al. The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res 2005; 14: 789-793.
27. Di Lorenzo G, Drago A, Esposito PM, et al. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Int Arch Allergy Immunol 2001; 125: 164-175.
28. Gevaert P, Bachert C, Holtappels G, et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy 2003; 58: 371-379.
29. Shahana S, Jaunmuktane Z, Asplund MS, et al. Ultrastructural investigation of epithelial damage in asthmatic and non-asthmatic nasal polyps. Respir Med 2006; 100: 2018-2028.
30. Higashi N, Taniguchi M, Mita H, et al. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. Clin Exp Allergy 2002; 32: 1484-1490.
31. Antczak A, Montuschi P, Kharitonov S, et al. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166: 301-306. (Pubitemid 34864417)
32. Sousa AR, Parikh A, Scadding G, et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347: 1493-1499.
33. Haruna S, Nakanishi M, Otori N, et al. Histopathological features of nasal polyps with asthma association: an immunohistochemical study. Am J Rhinol 2004; 18: 165-172.